Liriodenine inhibits dopamine biosynthesis and L-DOPA-induced dopamine content in PC12 cells

Archives of Pharmacal Research

Volumn 30, Issue 8, 2007, Pages 984-990

  Chun, Mei Jin ^a   Jae, Joon Lee ^a   Yoo, Jung Yang ^a   Yu, Mi Kim ^a   Young, Kyoon Kim ^b   Shi, Yong Ryu ^c   Myung, Koo Lee ^a  

^a Chungbuk National University   (South Korea)

^b Kookmin University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Aromatic L amino acid decarboxylase; Cyclic AMP; Intracellular Ca2+ concentration; L DOPA; Liriodenine; PC12 cells; TH mRNA; Tyrosine hydroxylase

Indexed keywords

APORPHINE DERIVATIVE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CALCIUM; CYCLIC AMP; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; LEVODOPA; LIRIODENINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MAGNOLIACEAE; METABOLISM; NORTHERN BLOTTING; RAT;

ANIMALS; APORPHINES; AROMATIC-L-AMINO-ACID DECARBOXYLASES; BLOTTING, NORTHERN; CALCIUM; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP; DOPAMINE; DOPAMINE ANTAGONISTS; LEVODOPA; MAGNOLIA; PC12 CELLS; RATS; TYROSINE 3-MONOOXYGENASE;

EID: 34548759729     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02993967     Document Type: Article

References (45)

1. Asencio, M., Delaquerriere, B., Cassels, B. K., Speisky, H., Comoy, E., and Protais, P., Biochemical and behavioral effects of boldine and glaucine on dopamine systems. Pharmacol. Biochem. Beh., 62, 7-13 (1999).
2. Byrd, J. C., Hadjiconstantinou, M., and Cavalla, D., Epinephrine synthesis in the PC12 pheochromocytoma cell line. Eur. J. Pharmacol., 127, 139-142 (1986).
3. Braun, A. P. and Schulman, H., The multifunctional calcium/calmodulin- dependent protein kinase. Ann. Rev. Physiol., 57, 417-445 (1995).
4. Cassels, B. K., Asencio, M., Conget, P., Speisky, H., Videla, L. A., and Lissi, E. A., Structure-antioxidative activity relationships in benzylisoquinoline lakaloids. Pharmacol. Res., 31, 103-107 (1995).
5. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
6. Clark, A. M., Watson, E. S., Ashfaq, M. K., and Hufford, C., In vivo efficacy of antifungal oxoaporphine alkaloids in experimental disseminated candidiasis. Pharmacol. Res., 4, 495-498 (1987).
7. Dong, X. P., Modranodnra, I. O., Che, C. T., Fong, H. S., and Farnsworth, N. R., Kmeriol and other aromatic constituents of Kmeria duperreana. Pharmacol. Res., 6, 637-640 (1989).
8. Elizabeth, A. Y., Anne-marie, D., and Norton, H. N., Parallel modulation of striatal dopamine synthetic enzymes by second messenger pathways. Eur. J. Pharmacol., 357, 15-23 (1998).
9. 2+ indicators with greatly improved fluorescent properties. J. Biol. Chem., 260, 3440-3450 (1985).
10. Graham, D. C., Tiffany, S. M., Bell, W. R. Jr., and Gutknecht, W. F., Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol., 14, 644-653 (1978).
11. Hwang, O., Kim, M. L., and Lee, J. D., Differential induction of gene expression of catecholamine biosynthetic enzymes and preferential increase in norepinephrine by forskolin. Biochem. Pharmacol., 48, 1927-1934 (1994).
12. Kim, K. S., Park, D. H., Wessel, T. C., Song, B., Wagner, J. A., and Joh, T. H., A dual role for the cAMP-dependent protein kinase in tyrosine hydroxylase gene expression. Proc. Natl. Acad. Sci. U.S.A., 90, 3471-3475 (1993).
13. Kim, Y. K. and Ryu, S. Y., Cytotoxic components from stem bark of Magnolia ovobata. Planta Med., 65, 291-292 (1999).
14. Kim, Y. M., Kim, M. N., Lee, J. J., and Lee, M. K., Inhibition of dopamine biosynthesis by tetrahydropapaveroline. Neurosci. Lett., 386, 1-4 (2005).
15. Lee, J. J., Kim, Y. M., Yin, S. Y., Park, H. D., Kang, M. H., Hong, J. T., and Lee, M. K., Aggravation of L-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells. Biochem. Pharmacol., 66, 1787-1795 (2003).
16. Lee, M. K., Nohta, H., and Ohkura, Y., Occurrence of aromatic L-amino acid decarboxylase in human plasma and its assay by high-performance liquid chromatograph with fluorescence detection. J. Chromatogr., 378, 329-336 (1986).
17. Lee, M. K. and Zhang, Y. H., Inhibition of tyrosine hydroxylase by berberine. Med. Sci. Res., 24, 561-562 (1996).
18. Lee, M. K., Zhang, Y. H., Shin, J. S., and Lee, S. S., Inhibition of tyrosine hydroxylase by hydrastine. Med. Sci. Res., 25, 619-620 (1997).
19. Lee, S. S., Kai, M., and Lee, M. K., Effects of natural isoquinoline alkaloids on monoamine oxidase activity in mouse brain: Inhibition by berebrine and palmatine. Med. Sci. Res., 27, 749-751 (1999a).
20. Lee, S. S., Yun-Choi, H. S., Kim, E. I., and Lee, M. K., Inhibition of monoamine oxidase by higenamine. Med. Sci. Res., 26, 71-72 (1999b).
21. Loghin, F., Chagraoui, A., Asencio, M., Comoy, E., Speisky, H, Cassels, B., and Protais, P., Effects of some antioxidative aporphine derivatives on striatal dopaminergic transmission and on MPTP-induced striatal dopamine depletion in B6CBA mice. Pharmacol. Sci., 18, 133-140 (2003).
22. Lowry, O. H., Rosenbrough, N. L., Farr, A. L., and Randall, R. L., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
23. Marsden, C. D., Parkinson's disease. J. Neurol. Neurosurg. Psychiatry, 57, 672-681 (1994).
24. Martinez, L. A., Rios, J. L., Paya, M., and Alcaraz, M. J., Inhibition of nonenzymic lipid peroxidation by benzylisoquinoline alkzloids. Free Rad. Biol. Med., 12, 287-292 (1992).
25. Mizushina , Y., Akihisa, T., Ukiya, M., Murakami, C., Kuriyama, I., Xu, X., Yoshida, H., and Sakaguchi, K., A novel DNA topoisomerase II inhibitor: dehydroebriconic acid, one of the lanostane-type triterpene acids from Poria cocos. Cancer Sci., 95, 354-360 (2004).
26. Nagatsu, T., Oka, K., and Kato, K., Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J. Chromatogr., 163, 247-252 (1979).
27. 1b receptors. Eur. J. Pharmacol., 267, 85-93 (1994).
28. Rosenberg, P. A., Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci., 8, 2887-2894 (1988)
29. Shin, J. S., Kim, E. I., Kai, M., and Lee, M. K., Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res., 25, 363-368 (2000).
30. Shin, J. S., Kim, K. T., and Lee, M. K., Inhibitory effects of bulbocapnine on dopamine biosynthesis in PC12 cells. Neurosci. Lett., 244, 161-164 (1998).
31. Shin, J. S., Lee, J. J., Kim, Y., Lee, C. K., Yun, Y. P., and Lee, M. K., Inhibitory effects of ethaverine, a homologue of papaverine, on dopamine content in PC12 cells. Biol. Pharm. Bull., 24, 103-105 (2001)
32. Shin, J. S., Yun-Choi, H. S., Kim, E. I., and Lee, M. K., Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med., 65, 452-455 (1999).
33. Tadaki, S., Nozaka, T., Yamada, S., Ishino, M., Morimoto, I., Tanaka, A., and Kunitomo, J., Clastogenicity of aporphine alkaloids in vitro. J. Pharmacobiodyn., 15, 501-512 (1992).
34. Thull, U., Kneubuhler, S., Gaillard, P., Carrupt, P. A., Testa, B., Altmoare, C., Carotti, A., Jenner, P., and McNaught, K. St. P., Inhibition of monoamine oxidase by isoquinoline derivatives. Biochem. Pharmacol., 50, 869-877 (1995)
35. Tischler, A. S., Perlman, R. L., Morse, G. M., and Sheard, B. E., Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell culture. J. Neurochem., 40, 364-370 (1983).
36. Walkinshaw, G. and Waters, C. M., Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. J. Clin. Invest., 95, 2458-2464 (1995).
37. Woo, S. H., Reynolds, M. S., Sun, N. J., Cassady, J. M., and Snapka, R. M., Inhibition of topoisomerase II by liriodenine. Biochem. Pharmacol., 54, 467-473 (1997).
38. Woo, S. H., Sun, N. J., Cassady, J. M., and Snapka, R. M., Topoisomerase II inhibition by aporphin alkaloids. Biochem. Pharmacol., 57, 1141-1145 (1999).
39. Wu, Y. C., Chang, G. Y., Duh, C. Y., and Wang, S. K., Cytotoxic alkaloids of Annona Montana. Phytochem., 33, 497-500 (1993).
40. Yin, S. Y., Kim, Y. M., Lee, J. J., Jin, C. M., Yang, Y. J., Ma, J. J., Kang, M. H., Kai, M., and Lee, M. K., Enantio-selective inhibition of (1R,9S)- and (1S,9R)-β-hydrastines on dopamine biosynthesis in PC12 cells. Neuropharmacol., 47, 1045-1052 (2004a).
41. Yin, S. Y., Lee, J. J., Kim, Y. M., Jin, C. M., Yang, Y. J., Kang, M. H., Kai, M., and Lee, M. K., Effects of (1R,9S)-β-hydrastine on L-DOPA-induced cytotoxicity in PC12 cells. Eur. J. Pharmacol., 488, 71-77 (2004b).
42. Youn, Y. C., Kwon, O. S., Han, E. S., Song, J. H., Shin, Y. K., and Lee, C. S., Protective effect of boldine on dopamine-induced membrane permeability transition in brain mitochondria and viability loss in PC12 cells. Biochem. Pharmacol., 63, 495-505 (2002).
43. Zetler, G., Neuroleptic-like, anticonvulsant and antinocieptive effects of aporphine alkaloids: Bulbocapinine, corytuberine, boldine and glaucine. Arch. Int. Pharmachodyn., 296, 255-281 (1988).
44. Zhang, Y. H., Shin, J. S., Lee, S.S., Kim, S. H., and Lee, M. K., Inhibition of tyrosine hydroxylase by bulbocapnine. Planta Med., 63, 362-363. (1997).
45. Ziv, I., Zilkha-Falb, R., Offen, D., Shirvan, A., Barzilai, A., and Melamed, E., Levodopa induces apoptosis in cultured neuronal cells: a possible accelerator of nigrostriatal degeneration in Parkinson's disease? Mov. Disord., 12, 17-23 (1997).